Genmab A/s
(NASDAQ) GMAB
Genmab A/s Financials at a Glance
Market Cap
$15.83B
Revenue (TTM)
$14.32B
Net Income (TTM)
$2.92B
EPS (TTM)
$1.55
P/E Ratio
16.47
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$25.68
Volume
101
Open
$25.67
Price
$25.68
Volume
101
Open
$25.67
Previous Close
$25.68
Daily Range
$25.63 - $26.23
52-Week Range
$17.23 - $35.43
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$25.68
Volume
101
Open
$25.67
Previous Close
$25.68
Daily Range
$25.63 - $26.23
52-Week Range
$17.23 - $35.43
GMAB News
GMAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,029
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GMAB Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
33%
Net Income Margin
17%
Return on Equity
18%
Return on Capital
11%
Return on Assets
5%
Earnings Yield
6.07%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$15.83B
Shares Outstanding
616.31M
Volume
101
Short Interest
0.00%
Avg. Volume
1.71M
Financials (TTM)
Gross Profit
$21.76B
Operating Income
$7.97B
EBITDA
$8.43B
Operating Cash Flow
$7.56B
Capital Expenditure
$236.00M
Free Cash Flow
$7.33B
Cash & ST Invst.
$10.91B
Total Debt
$35.36B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.72B
+4.4%
Gross Profit
$6.21B
+1.7%
Gross Margin
92.34%
N/A
Market Cap
$15.83B
N/A
Market Cap/Employee
$6.00M
N/A
Employees
2,638
N/A
Net Income
$196.98M
-94.9%
EBITDA
$1.54B
-34.4%
Quarterly Fundamentals
Net Cash
$24.45B
-221.8%
Accounts Receivable
$7.33B
+9.5%
Inventory
$114.46M
+84.6%
Long Term Debt
$33.51B
+3475.8%
Short Term Debt
$1.85B
+1911.4%
Return on Assets
4.95%
N/A
Return on Invested Capital
11.13%
N/A
Free Cash Flow
$1.83B
+511.6%
Operating Cash Flow
$1.91B
+486.4%